InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Lowdell Mark William, Directeur Scientifique. Officer active across 1 company, notably Inmune Bio, Inc.. Cumulatively, 8 filings have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €272k. History available since 7 July 2021. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Mark William Lowdell is the Chief Scientific Officer at Inmune Bio, Inc. In this role, he is responsible for leading the company's research and development initiatives. Mark William Lowdell plays a key role in innovation and scientific advancement within the organization. His expertise in biotechnology and life sciences is essential for supporting Inmune Bio's research objectives. He collaborates with multidisciplinary teams to develop innovative therapeutic solutions.